New treatment "breakthrough" for children with peanut allergy, study finds

The study, funded by Aimmune Therapeutics, included 551 participants, all of whom had peanut allergy. Participants ranged from 4 to 55 years of age, although most were children aged 4 to 17. Scientists were given a quarter of the placebo participants, while three quarters received oral doses of a small amount of peanut protein, half a miligram per day; the amount is gradually increased until a "maintenance dose" of 300 milligrams is achieved, corresponding to one peanut per day.

Source link